• Download
  • European research initiative for the prevention of Alzheimer’s dementia
  • Posted in News Review

  • 15th Apr 2015

  • The members of the EPAD initiative recently announced the start of a novel collaboration between academic and private sectors to test innovative treatments for the prevention of Alzheimer’s dementia.Previous attempts to bring new drugs for Alzheimer’s disease to the market have been disappointing despite a high level of investment. However, the realisation that Alzheimer’s disease […]

  • WFNR Franz Gerstenbrand Award now open for entries
  • Posted in News Review

  • 13th Mar 2014

  • To support Brain Awareness Week (10–16 March 2014), the World Federation for Neurorehabilitation (WFNR) has announced that the WFNR Franz Gerstenbrand Award is open for entries from  clinicians, researchers and allied health professionals to recognise and reward a neurorehabilitation project that has benefitted patients. “This is the second year of our Award and we’ve announced […]

  • News Review
  • Posted in News Review

  • 29th May 2013

  • Reader offer until 30th June 2013: Buy Principals of Neural Science at a reduced rate of £59.99

  • News Review
  • Posted in News Review

  • 12th Mar 2013

  • Alex Flynn – one man, one mission, £1 million for Parkinson’s Alex Flynn is a 41-year-old father of three boys, who has previously worked as a lawyer for numerous multinationals. However, more recently Alex has been concentrating on 10MillionMetres; a life-changing endurance project, the formation of which was encouraged as a consequence of him being […]

  • The use of Snoezelen in brain injury
  • Posted in News Review

  • 31st Jan 2013

  • Following the receipt of a donation of a significant amount of Snoezelen equipment, Mulberry House, one of the rehabilitation units owned by Titleworth Neuro, have developed a Sensory Room in order to provide sensory interventions for residents. Snoezelen is described as a multi-sensory intervention providing sensory stimuli to an individual’s primary senses of sight, hearing, […]

  • News Review
  • Posted in News Review

  • 30th Jan 2013

  • Marketing Authorisation extension for Gadovist® 1.0 (gadobutrol) in the whole body Bayer HealthCare’s Radiology and Interventional division has completed the necessary UK variation procedure for Gadovist®1.0 (gadobutrol) for the diagnosis of diseases in the whole body with magnetic resonance imaging. Based on the label extension, Gadovist 1.0 can be used in Europe for magnetic resonance […]


Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

See a sample email newsletter here
This website is for medical professionals only.